RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL

Genmab completes tender offer for Merus and opens subsequent offering period

NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment

Anixa Biosciences reveals final data from Phase one clinical trial of investigational breast cancer vaccine at 2025 San Antonio Breast Cancer Symposium

Privo Technologies doses first patient in first-in-human clinical trial of PRV131

Senhwa Biosciences signs clinical supply agreement with BeOne Medicines

D3 Bio completes USD108m Series B financing round

Champions Oncology expands bioanalytical services with new technology and leadership

Poolbeg Pharma trial to feature in major CRS research programme

DELFI Diagnostics presents preliminary data showing potential for blood-based lung cancer detection in non-smoking population

Natera acquires Foresight Diagnostics to expand MRD capabilities

FDA clears Bristol Myers Squibb's Breyanzi as first CAR T therapy for relapsed or refractory marginal zone lymphoma

OncoHost named Gold Winner in 2025 Merit Awards for Healthcare

Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA